SCHEMBL19854531

SCHEMBL19854531

C=CC(=O)NCCOc1ccc(CCCCCCCCC)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 6/20 0.59
THRA P10827 5/20 0.59
ALDH1A1 P00352 2/20 0.56
ZDHHC20 Q5W0Z9 1/20 0.52
ZDHHC2 Q9UIJ5 1/20 0.52
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPK1 P28482 1/20 0.52
CASP1 P29466 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
CNR1 P21554 1/20 0.50
CNR2 P34972 1/20 0.50
PLA2G4A P47712 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19856044 0.95 THRB (0.55) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL10363871 0.94 ZDHHC20 (0.58) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL10362588 0.93 THRB (0.58) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL10364148 0.89 TGM2 (0.56) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL19855999 0.88 THRB (0.51) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL19854538 0.87 THRB (0.47) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL19854984 0.86 THRB (0.51) THRBTHRAALDH1A1ZDHHC20ZDHHC2
SCHEMBL19855925 0.86 RAB9A (0.60) THRBTHRAALDH1A1MAPK1SMN1; SMN2
SCHEMBL10806715 0.85 ZDHHC2 (0.69) ZDHHC20ZDHHC2PLA2G4ATGM2
SCHEMBL10806059 0.85 ZDHHC2 (0.69) ZDHHC20ZDHHC2PLA2G4ATGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 THRB 3939/4885THRA 3929/4885ALDH1A1 3826/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 THRB 3939/4885THRA 3929/4885ALDH1A1 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.